Business Context and Reporting Period
This Form 8-K Current Report was filed by Olenox Industries Inc. on February 11, 2026, with the report dated February 18, 2026. The filing discloses material definitive agreements regarding debt and equity settlements and the appointment of a new director.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or liquidity ratios. The financial impact is limited to specific settlement transactions:
- Debt Settlement: The Company settled an outstanding convertible promissory note by issuing 626,325 shares of restricted common stock.
- Equity Settlement: The Company resolved claims regarding Series A Non-Voting Convertible Preferred Stock by issuing 585,000 shares of restricted common stock in exchange for the surrender of 39,000 Preferred Shares.
- Director Compensation: The new director will receive an annual cash retainer of $40,000, plus $10,000 for committee chair positions, and an annual equity grant valued at approximately $50,000.
Material Changes
Material changes reported in this filing include:
- Debt Elimination: Full settlement of a convertible promissory note owed to Michael McLaren via stock issuance, waiving all related claims.
- Capital Structure Adjustment: Conversion of 39,000 Preferred Shares into 585,000 Common Shares, resolving potential shareholder claims.
- Board Composition: Appointment of Ambassador Paula J. Dobriansky to fill a board vacancy, effective February 16, 2026.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, revenue outlook, or management commentary regarding future business performance. The primary risks and contingencies addressed are the resolution of past claims:
- Legal Contingencies Resolved: The settlement agreements include waivers and releases of all actual or potential claims by the Note Holder/Shareholder against the Company.
- Dilution Risk: The issuance of 1,211,325 total shares of restricted common stock to settle obligations may result in shareholder dilution.
Investor Verification Checklist
- Verify the exact terms and valuation of the convertible promissory note settled in Exhibit 10.1.
- Confirm the impact of the 1,211,325 new shares on total outstanding share count and earnings per share.
- Review the full text of the Settlement Agreements (Exhibits 10.1 and 10.2) for any hidden covenants or future obligations.
- Assess the strategic value of Ambassador Dobriansky's appointment relative to the Company's current business focus.